ROYAL BANK OF CANADA - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 48 filers reported holding ALPINE IMMUNE SCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$72,000
+166.7%
6,323
+139.3%
0.00%
Q2 2023$27,000
+170.0%
2,642
+99.1%
0.00%
Q1 2023$10,000
-56.5%
1,327
-57.9%
0.00%
Q4 2022$23,000
+2200.0%
3,155
+1560.5%
0.00%
Q3 2022$1,0000.0%190
+115.9%
0.00%
Q2 2022$1,000
-83.3%
88
-87.7%
0.00%
Q1 2022$6,000
-83.3%
713
-72.7%
0.00%
Q4 2021$36,000
+200.0%
2,612
+120.8%
0.00%
Q3 2021$12,000
+71.4%
1,183
+48.8%
0.00%
Q2 2021$7,000795
+9837.5%
0.00%
Q4 2020$0
-100.0%
8
-92.2%
0.00%
Q3 2020$1,000
-98.8%
103
-98.8%
0.00%
Q2 2020$81,000
+440.0%
8,353
+56.1%
0.00%
Q1 2020$15,000
+1400.0%
5,351
+2031.9%
0.00%
Q4 2019$1,0000.0%251
-29.7%
0.00%
Q3 2019$1,0000.0%357
+42.8%
0.00%
Q2 2019$1,000
-80.0%
250
-66.7%
0.00%
Q1 2019$5,000
+66.7%
7500.0%0.00%
Q4 2018$3,000
-40.0%
7500.0%0.00%
Q3 2018$5,000
-16.7%
7500.0%0.00%
Q2 2018$6,0000.0%7500.0%0.00%
Q1 2018$6,000
-25.0%
7500.0%0.00%
Q4 2017$8,000
+166.7%
750
+198.8%
0.00%
Q3 2017$3,0002510.00%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q2 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders